AP News

Accuray shares slide after sales report

Shares of Accuray Inc. continued to slide Friday, a day after the radiation-treatment equipment maker announced lower-than-expected revenue for its fiscal second quarter and said it planned job cuts.

THE SPARK: The Sunnyvale, Calif., company said late Thursday that it anticipates fiscal second-quarter revenue of $72 million to $75 million. That is down sharply from the $106.4 million in revenue it brought in the previous year's fiscal quarter. The revenue also falls short of the $93.8 million that analysts polled by FactSet had expected.

The company also plans to cut its workforce — which totaled 1,100 people as of June — by 13 percent.

Accuray blames problems with changes to its sales force, manufacturing and supply chain.

THE BIG PICTURE: For fiscal 2013, which runs through June, Accuray expects to post a loss of 87 to 95 cents per share, excluding one-time items, on revenue of $320 million to $330 million.

Analysts had forecast an adjusted loss of 55 cents per share on revenue of $406 million for the year.

THE ANALYSIS: J.P. Morgan analyst Tycho W. Peterson downgraded the stock to "Underweight" from "Neutral." The analyst competition the company faces, its own execution problems and the prospect of market-share losses and a cash burn "for the foreseeable future."

Jefferies analyst Raj Denhoy lowered his price target on the stock to $6.50 from $10 but kept a "Buy" rating. The analyst said in a research note Friday that a "reset" under new CEO Joshua Levine was expected, but the severity was a surprise.

Even so, Denhoy said he still thinks the company's technologies are valuable, supporting its stock in the long term.

SHARE ACTION: Down 19 percent, or $1.29, to $5.49 in Friday afternoon trading while broader trading indexes were nearly flat. The company's stock started sliding Thursday evening after it made the announcement.

The Good Business Issue
blog comments powered by Disqus